Testing of the Russian vaccine against coronavirus infection COVID-19 has already begun.
This is reported on Friday, March 20, the press service of Rospotrebnadzor.
According to the department, specialists of the state scientific center of virology and biotechnology “Vector” were engaged in development of drugs for prevention and control of coronavirus of a new type. It is noted that the task was to create the vaccine “in the shortest possible time. As a result, scientists created prototypes on six technological platforms.
The preparations are based on widely used recombinant viral vectors of influenza and measles. According to Rospotrebnadzor, the effectiveness of vaccines is already being tested on laboratory animals. This will make it possible to calculate the qualitative dosage and method of application of the drug. Approximately, the vaccine will be available in the fourth quarter of this year.
As News Front reported earlier, the first cases of new coronavirus infection COVID-19 were registered in China late last year. The disease has now acquired pandemic status.
COVID-19 affects the lung alveoli. Its key symptoms are elevated body temperature, which cannot be reduced with standard medications, as well as dry cough and breathing problems.
It is important to note that older people are at risk. Because of their weakened immune system, their bodies are unable to withstand the virus. At the same time, only 5% of those infected have the disease in a severe form. 15% have to be hospitalized. 80% have the disease in a mild form similar to a common cold.Coronavirus: Thousands of retired medics asked to return to NHS